图书简介
This definitive volume will provide the reader with up to date information and the most recent science of the fast-evolving area of nanobiotherapeutic-based blood substitutes. Long studied, there are recent updates that make their use in patients more promising, and with one product approved for human use, many more in the pipeline. These include 2nd generations and even third generation ones, the later with enhancement of red blood cell functions. In addition, there are carefully written and referenced updates on the recent history and products in the field, complete with pathophysiologic and pharmacologic studies to validate and verify the efficacy and safety of many of these new products.Key Features: o This is a high interdisciplinary area with publications in different specialty journalso This book allows top research from different areas to give overviews in their respective areas all in one booko Compact, easy to reference on update on nanobiotherapeutic based oxygen carriers and blood substitutes, all in one convenient format
Unlimited Potential of Nanobiotechnology Based Blood Substitutes, Artificial Cells and Nanobiotherapeutics (TMS Chang); General: Development and Future of Chinese Transfusion Medicine and Blood Substitutes (J Liu and C Yang); The Clinical Impact of Red Blood Cell Storage: What Have the RCTs Told Us? (CP Stowell); Rational, Evidence-Based Transfusion: A Physiologist’s Perspective (GP Biro); Hemoglobin-based Oxygen Carriers, Volume Expansion, Fluid Management and Anemia (TN Estep); Hemoglobin-Based Oxygen Carriers: Biotechnology-based Oxygen Carriers (TMS Chang); Hemoglobin-Glutamer 250 (bovine) [HBOC-201, Hemopure®] Clinical Use in South Africa and Comprehensive Review of Cardiac Outcomes and Risk/Benefit in Peer-Reviewed, Indexed Studies in Humans and Animal Models (JS Jahr, K Tseng, AP Brown and GP Dubé); Immune Safety Evaluation of Polymerized Porcine Hemoglobin (pPolyHb) — Potential Red Blood Cell Substitutes (H Zhu, K Yan, X Dang, H Huang, E Chen, B Chen, Chan Luo, TMS Chang, P Dai and C Chen); Hemoglobin-Based Oxygen Carriers and Inhaled Nitric Oxide (B Yu and WM Zapol); Hemoglobin-Based Oxygen Carriers and Myocardial Infarction: Assessment of Potential Mechanisms (TN Estep); Insights Into the Possible Mechanisms of Hemoglobin-based Oxygen Carrier-Mediated Bradycardia and Adverse Cardiac Effects Observed in Clinical Trials (HW Kim); Modulation of Oxygen Affinity in Hemoglobin-based Oxygen Carriers (EAM Alomari, L Ronda, S Bettati, A Mozzarelli and S Bruno ); Cysteine Mutations in Recombinant Fetal Hemoglobin Influence Oxidative Side-Reactions (K Kettisen and L Bülow); Analysis of Dimeric Aβ Subunit Exchange between Bis-PEGylated and Native Hemoglobins (T Matsuhira, K Yamamoto and H Sakai); Ring-Opening Polymerization of Hemoglobin Based on Supramolecular Chemistry (T Matsuhira, K Yamamoto and H Sakai); Hemoglobin-Based Oxygen Carriers with Antioxidant Activities: Unraveling of Hemoglobin Oxidative Toxicity: Thirty Years of Investigation (AI Alayash ); A Nanobiotechnologic Therapeutic that Transport Oxygen and Removes Oxygen Radicals (TMS Chang); Effects of Crosslinked Polyhemoglobin-Superoxide Dismutase-Catalase on Blood-Brain Barrier and Brain Edema in a Hemorrhagic Shock Transient Global Ischemia Rat Model (DD Powanda and TMS Chang); Strategies to Decrease the Oxidative Toxicity of Hemoglobin-Based Oxygen Carriers (L Zhoa); Enhancing the Stability of Lumbricus terrestris Erythrocruorin (LtEc) for Use as a Blood Substitute (B Timm and J Elmer); Dual Antioxidant and Pro-Oxidation Effects of Ascorbic Acid on Bovine Hemoglobin (G Chan and TMS Chang); Hemoglobin-Based Oxygen Carriers with Enhancement in Both Antioxidant Functions and Carbon Dioxide Transport: Soluble Nanobiotherapeutics with Enhancements of All Three Major Red Blood Cell Functions (TMS Chang); A Novel Nanobiotherapeutical Poly-[Hemoglobin-Superoxide Dismutase-Catalase-Carbonic Anhydrase] with No Cardiac Toxicity for the Resuscitation of a 90-minute Sustained Severe Hemorrhagic Shock Rat Model with Two-third Blood Volume Loss (Y Bian and TMS Chang); Long Term Safety and Immunological Effects of a Nanobiotherapeutic, Bovine Poly-[Hemoglobin-Catalase-Superoxide Dismutase-Carbonic Anhydrase], After Four Weekly 5% Blood Volume Toploading Followed by a Challenge of 30% Exchange Transfusion (G Chen and TMS Chang); Extraction of Superoxide Dismutase, Catalase and Carbonic Anhydrase from Stroma-free Red Blood Cell Hemolysate for the Preparation of the Nanobiotechnological Complex of PolyHemoglobin-superoxide Dismutase-Catalase-Carbonic anhydrase (C Guo, M Gynn and TMS Chang); Temperature Stability of Poly-[hemoglobin-superoxide Dismutase-Catalase-Carbonic anhydrase] in the Form of a Solution or In the Lyophilized Form During Storage at -80°C, 4°C, 25°C and 37°C or Pasteurization at 70°C (Y Bian, C Guo and TMS Chang); Biodegradable and Lipid Membrane Nanoencapsulated Nano-Artificial Cells: Nanotechnology-based Complete Artificial Red Blood Cells (TMS Chang ); Analysis of Polyethylene-Glycol-Polylactide Nano-Dimension Artificial Red Blood Cells in Maintaining Systemic Hemoglobin Levels and Prevention of Methemoglobin Formation (TMS Chang, DD Powanda D and WP Yu); Effects of PEG-PLA-Nano Artificial Cells Containing Hemoglobin on Kidney Function and Renal Histology in Rats (ZC Liu and TMS Chang); Long Term Effects on the Histology and Function of Livers And Spleens in Rats after 33% Toploading of PEG-PLA Nano-Artificial Red Blood Cells (ZC Liu and TMS Chang); Polylactide-Polyethylene Membrane Nanoencapsulated Polyhemoglobin-superoxide Dismutase-Catalase-Carbonic anhydrase. Nano-Artificial Red Blood Cells that Act as O₂ and CO₂ Carriers with Enhanced Antioxidant Activity (W Gao, Y Bian and TMS Chang); Possibility of Pre-Hospital Resuscitation using Hemoglobin Vesicles for Trauma Hemorrhagic Shock with Coagulopathy — Our Resuscitation Strategy (M Kinoshita and K Hagisawa); Translational Research of Hemoglobin Vesicles (Artificial Red Cells) for a Transfusion Alternative and O₂/CO Therapeutics (H Sakai, H Azuma, H Horinouchi and K Kobayashi); Hemoglobin Vesicles as a Transfusion Alternative for Perioperative Hemorrhage in Thoracic Surgery (M Kohno, R Hashimoto, H Onozawa, K Oiwa, H Horinouchi, H Sakai, K Kobayashi and M Iwazaki); Prevention of Methemoglobin Formation in Artificial Red Cells (Hemoglobin-Vesicles) (H Sakai and M Yamada); Carbon Monoxide-Bound Hemoglobin-Vesicles: Current Facts and Potential Medical Applications (K Taguchi, K Matsumoto, H Sakai, T Maruyama and M Otagiri); Influence of Hemoglobin Vesicles on Immune Function (H Azuma, M Fujihara and H Sakai); Cells, Tissues and Organs Preservation: Development of a New HBOC for Liver Allograft Preservation in Combination with Machine Perfusion — Clearing the Wait List (KD Vandegriff, A Malavalli and WR Light); OxyVita® Hb: A Step Forward in Delivering Oxygen Carrying Capacity for Therapeutic Applications (H Wollocko, J Harrington, JS Jahr, K Steier and J Wollocko); Functionality of Albumin-Derived Perfluorocarbon-Based Artificial Oxygen Carriers in the Langendorff Heart (KB Ferenz and M Kirsch); Nanobiotherapeutics as Preservation Fluids for Organs and Cells (TMS Chang, W Jiang, F D’Agnillo and S Razack ); Platelet: Polyhemoglobin-Fibrinogen: A Novel Oxygen Carrier with Platelet-like Properties in a Hemodilution Setting (NSW Wong and TMS Chang); Megakaryocytes and Platelets from Novel Human Adipose Tissue-Derived Mesenchymal Stem Cells: Development of Cell-based Regenerative Medicine (Y Ono-Uruga, K Tozawa, Y Ikeda and Y Matsubara);
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐